Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

To the Editors

A. Bush, F. M. de Benedictis, G. Hedlin, J. Y. Paton, G. Wennergren, N. M. Wilson
European Respiratory Journal 2009 33: 705-706; DOI: 10.1183/09031936.00177408
A. Bush
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. M. de Benedictis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Hedlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Y. Paton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Wennergren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. M. Wilson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

We welcome the important article delineating the difference between severity and control in asthma 1, but we wonder if, on reflection, a different nomenclature, with a broader scope, might be more useful in real life clinical practice. The authors' propose subgroups of severe asthma, where poor control for extraneous reasons (for example medication issues and/or associated co-morbidities) are included, although it was correctly pointed out that the term “severe” asthma should be reserved for those with a requirement for high intensity treatment. Typically, asthmatics come to a specialist clinic because of failure to respond to high dose therapy and, as discussed, there are many reasons for this.

We have proposed the umbrella term “problematic severe asthma” for these patients 2. They may have either or both of poor baseline control and severe exacerbations. The first step is a detailed multidisciplinary assessment, if possible including a home visit, reviewing records of dispensed prescription and a psychological assessment. This initial assessment leads to about half the patients being placed in the “difficult” category 3. Their problem (i.e. poor compliance) may not be easily resolved but they are clearly not candidates for potentially toxic therapies, such as cyclosporin or etanercept. The remainder then should have a detailed assessment of airway inflammation and an evaluation of the response to intramuscular triamcinolone (or another reliable method of administering corticosteroids which cuts out uncertainty of patient adherence) to determine steroid responsiveness. Most, but not all of this group, will turn out to be truly “severe, therapy-resistant”, whose exacerbations, poor baseline control or both, may need innovative therapies. Our view is that different names for specific categories will lead to a reduction in the current confusion in the literature which has been highlighted 1. Our suggestion, shown in figure 1⇓, emphasises the distinction between difficult-to-treat asthma and severe, therapy resistant asthma. In fact, the same concept applies at any level of asthma severity; poorly controlled asthma deserves consideration of the reason for the difficulty before costly treatment is increased.

Fig. 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1—

Suggested nomenclature of subgroups of problematic severe asthma.

Statement of interest

Statements of interest for F.M. de Benedictis and G. Wennergren can be found at www.erj.ersjournals.com/misc/statements.shtml

    • © ERS Journals Ltd

    References

    1. ↵
      Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008;32:545–554.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Bush A, Hedlin G, Carlsen KH, et al. Severe childhood asthma: a common international approach?. Lancet 2008;372:1019–1021.
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      Bracken M, Fleming L, Hall P, et al. Results of nurse-led home visits for children with difficult asthma. Thorax 2007;62: Suppl. 111 A21–A22.
      OpenUrl
    PreviousNext
    Back to top
    View this article with LENS
    Vol 33 Issue 3 Table of Contents
    European Respiratory Journal: 33 (3)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    To the Editors
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    To the Editors
    A. Bush, F. M. de Benedictis, G. Hedlin, J. Y. Paton, G. Wennergren, N. M. Wilson
    European Respiratory Journal Mar 2009, 33 (3) 705-706; DOI: 10.1183/09031936.00177408

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    To the Editors
    A. Bush, F. M. de Benedictis, G. Hedlin, J. Y. Paton, G. Wennergren, N. M. Wilson
    European Respiratory Journal Mar 2009, 33 (3) 705-706; DOI: 10.1183/09031936.00177408
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Rifapentine access in Europe: concerns over key TB treatment
    • Balancing the risks and benefits of in-circuit bacterial filters
    • Prednisolone plus itraconazole in acute-stage ABPA complicating asthma
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2022 by the European Respiratory Society